Roche will publish its Full Year Results for 2022 prior to the opening of the Swiss Stock Exchange on Thursday, 2 February 2023.

Release will be e-mailed and posted on the Roche IR website.

The webinar will start with presentations by senior management, followed by a Q&A session.

Presenters: Severin Schwan, CEO Roche Group

Thomas Schinecker, CEO Roche Pharmaceuticals ad interim

Matt Sause, CEO Roche Diagnostics

Alan Hippe, Chief Financial and IT Officer

We would like to invite all interested parties to participate in the webinar and to pre-register for the event here

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

Contact:

Dr. Bruno Eschli

Tel: +41 61 68-75284

Email: bruno.eschli@roche.com

(C) 2022 Electronic News Publishing, source ENP Newswire